BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 16206348)

  • 1. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
    Alvarez-Nemegyei J; Cen-Pisté JC; Medina-Escobedo M; Villanueva-Jorge S
    J Rheumatol; 2005 Oct; 32(10):1923-7. PubMed ID: 16206348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
    Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
    J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of musculoskeletal pain, associated sociodemographic factors, and disability in Pakistan.
    Ahmed H; Saeed MA; Attique F
    Int J Rheum Dis; 2024 Jan; 27(1):e14972. PubMed ID: 37997543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for ulceration over tophi in patients with gout.
    Xu J; Lin C; Zhang P; Ying J
    Int Wound J; 2017 Aug; 14(4):704-707. PubMed ID: 27723248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Risk Factors for Changes in the Renal Two-Dimensional Image in Gout Patients.
    Dang W; Xu X; Luo D; Luo H; Hu J; Zhou J; Liu J; You L
    Int J Gen Med; 2021; 14():6367-6378. PubMed ID: 34675606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study.
    Oka P; Chong WM; Ng DX; Aau WK; Tan NC
    Front Med (Lausanne); 2023; 10():1253839. PubMed ID: 37746085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity burden in terms of disability in patients with osteoarthritis in Mexico. The IMPACTAR registry.
    Vega-Morales D; Esquivel-Valerio JA; Vázquez-Fuentes BR; Díaz-Borjón A; Arce-Salinas CA; Álvarez-Hernández E; Torres-Roldán JF; Aguilera-Zepeda JM; Toledo-Infanson V; Alcántar-Luna E; Aldrete-Velasco JA; Martínez Hernández JL; Gutiérrez-Gómez JJ; Espinosa-Morales R;
    Reumatol Clin (Engl Ed); 2020 Jun; ():. PubMed ID: 32563732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hygiene hypothesis in allergy and asthma: an update.
    Brooks C; Pearce N; Douwes J
    Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):70-7. PubMed ID: 23103806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications.
    Anders HJ; Li Q; Steiger S
    Clin Kidney J; 2023 Jun; 16(6):928-938. PubMed ID: 37261000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
    Gwinnutt JM; Wieczorek M; Cavalli G; Balanescu A; Bischoff-Ferrari HA; Boonen A; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
    Wieczorek M; Gwinnutt JM; Ransay-Colle M; Balanescu A; Bischoff-Ferrari H; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm TA; Walker-Bone K; Welling J; Zlatkovic-Svenda M; Verstappen SM; Guillemin F
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35351808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities.
    Stamp LK; Farquhar H; Pisaniello HL; Vargas-Santos AB; Fisher M; Mount DB; Choi HK; Terkeltaub R; Hill CL; Gaffo AL
    Nat Rev Rheumatol; 2021 Oct; 17(10):633-641. PubMed ID: 34331037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of activity limitation in people with gout: a prospective study.
    Stewart S; Rome K; Eason A; House ME; Horne A; Doyle AJ; Knight J; Taylor WJ; Dalbeth N
    Clin Rheumatol; 2018 Aug; 37(8):2213-2219. PubMed ID: 29680870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in gout in primary care: Baseline findings from a cohort study.
    Chandratre P; Mallen C; Richardson J; Muller S; Hider S; Rome K; Blagojevic-Bucknall M; Roddy E
    Semin Arthritis Rheum; 2018 Aug; 48(1):61-69. PubMed ID: 29398125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "You want to get on with the rest of your life": a qualitative study of health-related quality of life in gout.
    Chandratre P; Mallen CD; Roddy E; Liddle J; Richardson J
    Clin Rheumatol; 2016 May; 35(5):1197-205. PubMed ID: 26245722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR).
    Scire CA; Manara M; Cimmino MA; Govoni M; Salaffi F; Punzi L; Monti MC; Carrara G; Montecucco C; Matucci-Cerinic M; Minisola G;
    Arthritis Res Ther; 2013 Aug; 15(5):R101. PubMed ID: 24004577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in gout: a systematic review.
    Chandratre P; Roddy E; Clarson L; Richardson J; Hider SL; Mallen CD
    Rheumatology (Oxford); 2013 Nov; 52(11):2031-40. PubMed ID: 23934311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease in gout in a managed care setting.
    Fuldeore MJ; Riedel AA; Zarotsky V; Pandya BJ; Dabbous O; Krishnan E
    BMC Nephrol; 2011 Aug; 12():36. PubMed ID: 21812963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficult-to-treat gouty arthritis: a disease warranting better management.
    Schlesinger N
    Drugs; 2011 Jul; 71(11):1413-39. PubMed ID: 21812506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?
    Stamp LK; Khanna PP; Dalbeth N; Boers M; Maksymowych WP; Schumacher HR; Becker MA; MacDonald PA; Edwards NL; Singh JA; Simon LS; McQueen FM; Neogi T; Gaffo AL; Strand V; Taylor WJ
    J Rheumatol; 2011 Jul; 38(7):1462-6. PubMed ID: 21724717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.